相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Germline biallelic PIK3CG mutations in a multifaceted immunodeficiency with immune dysregulation
Marini Thian et al.
HAEMATOLOGICA (2020)
Cracking the context-specific PI3K signaling code
Ralitsa R. Madsen et al.
SCIENCE SIGNALING (2020)
MiR-1976 knockdown promotes epithelial-mesenchymal transition and cancer stem cell properties inducing triple-negative breast cancer metastasis
Jingyi Wang et al.
CELL DEATH & DISEASE (2020)
Discovery of Potent and Selective PI3Kγ Inhibitors
Samuel L. Drew et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer
Panpan Zhang et al.
CANCER LETTERS (2019)
The identification of key genes in nasopharyngeal carcinoma by bioinformatics analysis of high-throughput data
Yanshan Ge et al.
MOLECULAR BIOLOGY REPORTS (2019)
A class of highly selective inhibitors bind to an active state of PI3Kγ
Gangadhara Gangadhara et al.
NATURE CHEMICAL BIOLOGY (2019)
PI3K isoforms in cell signalling and vesicle trafficking
Benoit Bilanges et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
Fabrice Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments
Glenn R. Masson et al.
NATURE METHODS (2019)
p110γ deficiency protects against pancreatic carcinogenesis yet predisposes to diet-induced hepatotoxicity
Carolina Torres et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
Neil Vasan et al.
SCIENCE (2019)
Human PI3Kγ deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathology
Andrew J. Takeda et al.
NATURE COMMUNICATIONS (2019)
Binimetinib plus Gemcitabine and Cisplatin Phase I/II Trial in Patients with Advanced Biliary Cancers
Maeve A. Lowery et al.
CLINICAL CANCER RESEARCH (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome
Xiang Shu et al.
CARCINOGENESIS (2018)
Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases
Gillian L. Dornan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer
Daniel Nava Rodrigues et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Structural Basis for Regulation of Phosphoinositide Kinases and Their Involvement in Human Disease
John E. Burke
MOLECULAR CELL (2018)
TLR Crosstalk Activates LRP1 to Recruit Rab8a and PI3Kγ for Suppression of Inflammatory Responses
Lin Luo et al.
CELL REPORTS (2018)
Phosphatidylinositol 3-Kinase, Growth Disorders, and Cancer
Marcus D. Goncalves et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Inhalation of the prodrug PI3K inhibitor CL27c improves lung function in asthma and fibrosis
Carlo C. Campa et al.
NATURE COMMUNICATIONS (2018)
Gaussian Accelerated Molecular Dynamics in NAMD
Yui Tik Pang et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2017)
Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in PIK3CD and PIK3R1
Gillian L. Dornan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
PI3Kγ activity in leukocytes promotes adipose tissue inflammation and early-onset insulin resistance during obesity
Ludovic Breasson et al.
SCIENCE SIGNALING (2017)
Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral Angles
Brian S. Safina et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Deconvolution of Buparlisib's mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic intervention
Thomas Bohnacker et al.
NATURE COMMUNICATIONS (2017)
AACR Project GENIE: Powering Precision Medicine through an International Consortium
Fabrice Andre et al.
CANCER DISCOVERY (2017)
PI3Kγ activity in leukocytes promotes adipose tissue inflammation and early-onset insulin resistance during obesity
Ludovic Breasson et al.
SCIENCE SIGNALING (2017)
The PI3K Pathway in Human Disease
David A. Fruman et al.
CELL (2017)
Identification of allosteric binding sites for PI3Kα oncogenic mutant specific inhibitor design
Michelle S. Miller et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
The Rational Design of Selective Benzoxazepin Inhibitors of the α-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326)
Timothy P. Heffron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
Olivier De Henau et al.
NATURE (2016)
PI3Kγ is a molecular switch that controls immune suppression
Megan M. Kaneda et al.
NATURE (2016)
Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate
Catherine A. Evans et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression
Megan M. Kaneda et al.
CANCER DISCOVERY (2016)
PI3Kδ and primary immunodeficiencies
Carrie L. Lucas et al.
NATURE REVIEWS IMMUNOLOGY (2016)
MDTraj: A Modern Open Library for the Analysis of Molecular Dynamics Trajectories
Robert T. McGibbon et al.
BIOPHYSICAL JOURNAL (2015)
Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase δ
John R. Somoza et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Gaussian Accelerated Molecular Dynamics: Unconstrained Enhanced Sampling and Free Energy Calculation
Yinglong Miao et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
James A. Maier et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
The regulatory subunits of PI3Kγ control distinct neutrophil responses
Arnaud Deladeriere et al.
SCIENCE SIGNALING (2015)
The regulatory subunits of PI3Kγ control distinct neutrophil responses
Arnaud Deladeriere et al.
SCIENCE SIGNALING (2015)
FEM: feature-enhanced map
Pavel V. Afonine et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2015)
Structural Basis for Isoform Selectivity in a Class of Benzothiazole Inhibitors of Phosphoinositide 3-Kinase γ
Philip N. Collier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia
Jennifer R. Brown et al.
BLOOD (2014)
Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma
Ian W. Flinn et al.
BLOOD (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Rab8a interacts directly with PI3Kγ to modulate TLR4-driven PI3K and mTOR signalling
Lin Luo et al.
NATURE COMMUNICATIONS (2014)
Signaling by the Phosphoinositide 3-Kinase Family in Immune Cells
Klaus Okkenhaug
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation
Pascal Furet et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergy
Emilie Collmann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Molecular determinants of PI3Kγ-mediated activation downstream of G-protein-coupled receptors (GPCRs)
Oscar Vadas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Phosphoinositide 3-Kinase δ Gene Mutation Predisposes to Respiratory Infection and Airway Damage
Ivan Angulo et al.
SCIENCE (2013)
PKCβ Phosphorylates PI3Kγ to Activate It and Release It from GPCR Control
Romy Walser et al.
PLOS BIOLOGY (2013)
Towards automated crystallographic structure refinement with phenix.refine
Pavel V. Afonine et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2012)
Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway
Ian Bruce et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
PI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma
Francesco Dituri et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA
Marjorie J. Lindhurst et al.
NATURE GENETICS (2012)
Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110α (PIK3CA)
John E. Burke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Receptor Tyrosine Kinases and TLR/IL1 Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
Michael C. Schmid et al.
CANCER CELL (2011)
LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery
Roman A. Laskowski et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory Mechanism
Xuxiao Zhang et al.
MOLECULAR CELL (2011)
Integrating Cardiac PIP3 and cAMP Signaling through a PKA Anchoring Function of p110γ
Alessia Perino et al.
MOLECULAR CELL (2011)
Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega
Fabian Sievers et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases
Oscar Vadas et al.
SCIENCE SIGNALING (2011)
Dynamics of the Phosphoinositide 3-Kinase p110δ Interaction with p85α and Membranes Reveals Aspects of Regulation Distinct from p110α
John E. Burke et al.
STRUCTURE (2011)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Key Role of Phosphoinositide 3-Kinase Class IB in Pancreatic Cancer
Charlotte E. Edling et al.
CLINICAL CANCER RESEARCH (2010)
Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound 26 (PKI-587), a Highly Efficacious Dual Inhibitor
Aranapakam M. Venkatesan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors
Alex Berndt et al.
NATURE CHEMICAL BIOLOGY (2010)
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin
Steven D. Knight et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Essential role of phosphoinositide 3-kinase gamma in eosinophil chemotaxis within acute pulmonary inflammation
Matthew Thomas et al.
IMMUNOLOGY (2009)
Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87/p110γ
Barbara Kurig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane
Diana Mandelker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
PI3Kγ Adaptor Subunits Define Coupling to Degranulation and Cell Motility by Distinct PtdIns(3,4,5)P3 Pools in Mast Cells
Thomas Bohnacker et al.
SCIENCE SIGNALING (2009)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
A pharmacological map of the PI3-K family defines a role for p110α in insulin signaling
Zachary A. Knight et al.
CELL (2006)
Oncogenic transformation induced by the p110β, -γ, and -δ isoforms of class I phosphoinositide 3-kinase
S Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A pharmacological map of the PI3-K family defines a role for p110 alpha in insulin signaling
Zachary A. Knight et al.
CELL (2006)
The Amber biomolecular simulation programs
DA Case et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus
DF Barber et al.
NATURE MEDICINE (2005)
Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis
M Camps et al.
NATURE MEDICINE (2005)
p84, a new Gβγ-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110γ
S Suire et al.
CURRENT BIOLOGY (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
PI3Kγ modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects
E Patrucco et al.
CELL (2004)
Baculovirus expression system for heterologous multiprotein complexes
I Berger et al.
NATURE BIOTECHNOLOGY (2004)
Tumour biology - Weakening link to colorectal cancer?
M Barbier et al.
NATURE (2001)
Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase γ
ME Pacold et al.
CELL (2000)
Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kγ
T Sasaki et al.
NATURE (2000)
Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation
E Hirsch et al.
SCIENCE (2000)
Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction
Z Li et al.
SCIENCE (2000)
Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration
T Sasaki et al.
SCIENCE (2000)
分享论文
